• 1
    Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987; 7:764772.MEDLINE
  • 2
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sodovsky R, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303:833841.MEDLINE
  • 3
    Chisari F. Immunobiology and pathogenesis of viral hepatitis. In: MRizzetto, RPurcell, JGerin, GVerme eds. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica. 1997; 2133.
  • 4
    Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1988; 145:34423449.
  • 5
    Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992; 89:8796.MEDLINE
  • 6
    Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 1987; 139:20502058.MEDLINE
  • 7
    Ferrari C, Penna A, Sansoni P, Guiberti T, Neri TM, Chisari FV, Fiaccadori F. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol 1986; 66:497506.MEDLINE
  • 8
    Anastassakos C, Alexander GJ, Wolstencroft RA, Dumonde DC, Eddleston AL, Williams R. Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers. Clin Exp Immunol 1987; 68:1522.MEDLINE
  • 9
    Anastassakos C, Alexander GJ, Wolstencroft RA, Avery JA, Portmann BC, Panyi GS, Dumonde DC, et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988; 94:9991005.MEDLINE
  • 10
    Nouri-Aria KT, Magrin S, Alexander GJ, Anderson MG, Williams R, Eddleston AL. Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction? Immunology 1988; 64:733738.MEDLINE
  • 11
    Tennant BC, Gerin JL. The woodchuck model of hepatitis B virus infection. In: IMArias, JBoyer, NFausto, WBJakoby, DSchachter, DAShafritz eds. The Liver: Biology and Pathology.3rd ed. New York: Raven. 1994; 14551466.
  • 12
    Cote P, Gerin J. The woodchuck as a model of hepadnavirus infection, pathogenesis and therapy. FORUM—Trends in Experimental and Clinical Medicine 1996; 6:131159.
  • 13
    Cote P, Nakamura I, Bellezza C, Tennant B, Gerin J. Immunobiology of the woodchuck and woodchuck hepatitis virus infection. In: MRizzetto, RPurcell, JGerin, GVerme eds. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica. 1997; 157163.
  • 14
    Cote PJ. Immunology of hepadnavirus infection in woodchucks. In: KHMeyer zum Buschenfelde, JHoofnagle, MManns eds. Immunology and Liver. Boston: Kluwer Academic Publishers. 1993; 5260.
  • 15
    Cote P, Korba B, Miller R, Jacob J, Baldwin B, Hornbuckle W, Purcell R, Tennant B, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000; 31:190200.MEDLINE
  • 16
    Korba BE, Cote PJ, Wells FV, Baldwin B, Popper H, Purcell RH, Tennant BC, et al. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 1989; 63:13601370.MEDLINE
  • 17
    Korba BE, Brown TL, Wells FV, Baldwin B, Cote PJ, Steinberg H, Tennant BC, et al. Natural history of experimental woodchuck hepatitis virus infection: Molecular virologic features of the pancreas, kidney, ovary, and testis. J Virol 1990; 64:44994506.MEDLINE
  • 18
    Cote PJ, Roneker C, Cass K, Schödel F, Peterson D, Tennant B, de Noronha F, et al. New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection. Viral Immunol 1993; 6:161169.MEDLINE
  • 19
    Cote PJ, Gerin JL. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection. Hepatology 1995; 22:687699.MEDLINE
  • 20
    Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H, Gerin JL. Hepatocellular carcinoma in woodchuck hepatitis virus–infected woodchucks. Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 1989; 9:461470.MEDLINE
  • 21
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156169.MEDLINE
  • 22
    Hoofnagle JH. Type B hepatitis: virology, serology and clinical course. Semin Liver Dis 1981; 1:714.MEDLINE
  • 23
    Cote PJ, Shapiro M, Engle RE, Popper H, Purcell RH, Gerin JL. Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen. J Virol 1986; 60:895901.MEDLINE
  • 24
    Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825829.MEDLINE
  • 25
    Cote PJ, Korba BE, Steinberg H, Ramirez-Mejia C, Baldwin B, Hornbuckle WE, Tennant BC, et al. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol 1991; 146:31383144.MEDLINE
  • 26
    Cote PJ, Korba BE, Baldwin B, Hornbuckle WE, Tennant BC, Gerin JL. Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks. J Infect Dis 1992; 166:628631.MEDLINE
  • 27
    Menne S, Maschke J, Tolle TK, Lu M, Roggendorf M. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol 1997; 71:6574.MEDLINE
  • 28
    Menne S, Maschke J, Lu H, Grosse-Wilde H, Roggendorf M. T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J Virol 1998; 72:60836091.MEDLINE
  • 29
    Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 1994; 68:57925803.MEDLINE
  • 30
    Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 1987; 139:539544.MEDLINE
  • 31
    Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996; 8:478483.MEDLINE
  • 32
    Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:2536.MEDLINE
  • 33
    Nakamura I, Nupp JT, Rao BS, Buckler-White A, Casey JL, Gerin JL, Cote PJ. Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3( with applications for the detection of RNA expression in tissues by RT-PCR assay. J Med Virol 1997; 53:8595.MEDLINE